Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole

NCT00640809 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Bowel Diseases, Inflammatory

Interventions

DRUG: Celecoxib
OTHER: Placebo
DRUG: Ibuprofen plus Omeprazole

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.